news
Philippines may re-introduce controversial dengue vaccine
The Philippines is considering re-introducing a dengue vaccine whose use was ceased because of links to several deaths.
List view / Grid view
Dengvaxia
article
Climate change: how pharma will profit from a warming planet
Rising temperatures will likely accelerate the spread of vector-borne diseases, resulting in an increased demand for vaccines. European Pharmaceutical Review investigates a Morgan Stanley report on the pharmaceutical beneficiaries of climate change.
news
Sanofi sends half a million dengue vaccines to high risk Brazilians
15 August 2016 | By Sanofi
Results of the study affirm the vaccine's consistent efficacy in reducing dengue in two-thirds of the study participants, aged 9 and older. It also documents the ability of the vaccine to prevent 8 out of 10 hospitalisations and up to 93% of severe dengue cases in this age group during…
news
World’s first public dengue immunisation programme starts
5 April 2016 | By Victoria White
Dengvaxia vaccinations of one million students from 6,000 public schools in the Philippines are to begin this year...
news
Sanofi Pasteur’s Dengvaxia approved in Brazil
Dengvaxia was shown to reduce dengue due to all four serotypes in two-thirds of the participants in clinical trials and prevent 8 out of 10 hospitalisations due to dengue and up to 93% of severe dengue cases...
news
Sanofi Pasteur’s Dengvaxia approved in the Philippines
Dengvaxia is the first vaccine licensed for the prevention of dengue in the world...
